ArticleActa neuropathologica communications2021

Systemic delivery of a specific antibody targeting the pathological N-terminal truncated tau peptide reduces retinal degeneration in a mouse model of Alzheimer's Disease.

Valentina Latina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.